Diversify Wealth Management LLC increased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 16.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,166 shares of the healthcare conglomerate's stock after purchasing an additional 1,678 shares during the period. Diversify Wealth Management LLC's holdings in UnitedHealth Group were worth $6,335,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also bought and sold shares of the company. State Street Corp lifted its position in UnitedHealth Group by 1.3% in the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate's stock valued at $26,626,387,000 after acquiring an additional 563,554 shares in the last quarter. Geode Capital Management LLC grew its holdings in UnitedHealth Group by 1.6% during the third quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate's stock worth $11,440,133,000 after buying an additional 318,039 shares in the last quarter. Franklin Resources Inc. boosted its holdings in UnitedHealth Group by 2.5% during the 3rd quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate's stock worth $4,884,019,000 after acquiring an additional 193,800 shares during the last quarter. International Assets Investment Management LLC raised its holdings in shares of UnitedHealth Group by 78,814.4% in the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate's stock valued at $3,096,896,000 after purchasing an additional 5,290,025 shares during the last quarter. Finally, Ameriprise Financial Inc. grew its position in UnitedHealth Group by 0.6% in the 2nd quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate's stock worth $1,920,039,000 after purchasing an additional 21,149 shares in the last quarter. Institutional investors own 87.86% of the company's stock.
UnitedHealth Group Price Performance
Shares of UnitedHealth Group stock traded down $0.56 during trading on Monday, hitting $510.03. The stock had a trading volume of 7,462,712 shares, compared to its average volume of 5,104,531. The firm has a market cap of $469.37 billion, a price-to-earnings ratio of 33.23, a P/E/G ratio of 1.42 and a beta of 0.62. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The business's 50-day moving average is $549.37 and its 200 day moving average is $563.70. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company's revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter last year, the business posted $5.83 earnings per share. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.65%. UnitedHealth Group's dividend payout ratio (DPR) is 54.72%.
Analysts Set New Price Targets
UNH has been the subject of several recent analyst reports. KeyCorp reaffirmed an "overweight" rating and issued a $650.00 target price on shares of UnitedHealth Group in a report on Friday. Piper Sandler lowered their target price on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research note on Thursday, January 2nd. Deutsche Bank Aktiengesellschaft raised their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a report on Tuesday, December 3rd. Cantor Fitzgerald reissued an "overweight" rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday. Finally, UBS Group dropped their price objective on UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating on the stock in a research note on Wednesday, October 16th. Two investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of "Buy" and a consensus target price of $627.74.
Get Our Latest Stock Report on UNH
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.